Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)
NCT ID: NCT05558813
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-11-30
2029-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
NCT02921321
Cardiac Magnetic Resonance in Children With Muscular Dystrophy
NCT01081080
IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévère
NCT02078076
Heart Imaging in Children With Muscular Dystrophy
NCT01633242
Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy
NCT01295385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DMD-CMP cohort
Minor (≥ 6 years) and major patients with genetically proven Duchenne myopathy
Cardiac MRI
two cardiac MRIs with Gadolinum injection at 2-year intervals
Blood assays
blood samples for the determination of blood biomarkers of heart failure (BNP, NTproBNP) and for the constitution of a biological collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac MRI
two cardiac MRIs with Gadolinum injection at 2-year intervals
Blood assays
blood samples for the determination of blood biomarkers of heart failure (BNP, NTproBNP) and for the constitution of a biological collection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Genetically proven Duchenne muscular dystrophy
* Affiliation to French medical insurance
* Informed consent provided
Exclusion Criteria
* Left ventricular ejection fraction \<30%
* Tracheostomy of hospitalisation for acute respiratory failure \<1 year
* Contraindication to MRI: claustrophobia, Gadolinum allergy
6 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karim A WAHBI, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necker Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03534-35
Identifier Type: OTHER
Identifier Source: secondary_id
APHP220088
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.